Skip to Content

Atenolol and Chlorthalidone Tablets

Last Updated: December 13, 2018
Status: Resolved

Products Affected - Description
    • Atenolol and Chlorthalidone oral tablet, Mylan, 100 mg/25 mg, 100 count, NDC 00378-2064-01
    • Atenolol and Chlorthalidone oral tablet, Mylan, 50 mg/25 mg, 100 count, NDC 00378-2063-01
Reason for the Shortage
    • Almatica Pharma has Tenoretic available.
    • Mylan has discontinued the production of atenolol/chlorthalidone tablets.
    • Teva did not provide a reason for the shortage.
Available Products
    • Tenoretic oral tablet, Almatica Pharma, 100 mg/25 mg, 90 count, NDC 52427-0383-90
    • Tenoretic oral tablet, Almatica Pharma, 50 mg/25 mg, 90 count, NDC 52427-0382-90
    • Atenolol and Chlorthalidone oral tablet, Teva, 100 mg/25 mg, 100 count, NDC 00591-5783-01
    • Atenolol and Chlorthalidone oral tablet, Teva, 50 mg/25 mg, 100 count, NDC 00591-5782-01

Estimated Resupply Dates

    • All marketed presentations are available.

Alternative Agents & Management

    • Atenolol and chlorthalidone tablets are available as individual products.

Updated

Updated December 13, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created August 1, 2018 by Anthony Trovato, Pharmacy Resident. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide